Loxapine Succinate
Loxapine Succinate Brand names, Loxapine Succinate Analogs
Loxapine Succinate Brand Names Mixture
- No information avaliable
Loxapine Succinate Chemical_Formula
C18H18ClN3O
Loxapine Succinate RX_link
http://www.rxlist.com/cgi/generic2/loxapineoc.htm
Loxapine Succinate fda sheet
Loxapine Succinate msds (material safety sheet)
Loxapine Succinate Synthesis Reference
Neth. pat. Appl. 6,406,089 corresp to Schmutz et al., U.S. pat. 3,546,226 (1964, 1970 both to Wander)
Loxapine Succinate Molecular Weight
327.808 g/mol
Loxapine Succinate Melting Point
109-110 oC
Loxapine Succinate H2O Solubility
No information avaliable
Loxapine Succinate State
Solid
Loxapine Succinate LogP
3.162
Loxapine Succinate Dosage Forms
Tablet; Capsule; Oral solution; IV solution; IM solution
Loxapine Succinate Indication
For the management of the manifestations of psychotic disorders
Loxapine Succinate Pharmacology
Loxapine, a dibenzoxazepine compound, represents a subclass of tricyclic antipsychotic agents, chemically distinct from the thioxanthenes, butyrophenones, and phenothiazines. Pharmacologically, Loxapine is a tranquilizer for which the exact mode of action has not been established.
Loxapine Succinate Absorption
Systemic bioavailability of the parent drug was only about one third that after an equivalent intramuscular dose (25 mg base) in male volunteers
Loxapine Succinate side effects and Toxicity
LD50=65 mg/kg (Orally in mice)
Loxapine Succinate Patient Information
Loxapine Succinate Organisms Affected
Humans and other mammals
